SARS-CoV-2 vaccine effectiveness and breakthrough infections in maintenance dialysis patients

Harold J. Manley, Gideon N. Aweh, Caroline M. Hsu, Daniel E. Weiner, Dana Miskulin, Antonia M. Harford, Doug Johnson, Eduardo K. Lacson
doi: https://doi.org/10.1101/2021.12.20.21268124

Article usage

Article usage: December 2021 to August 2025

AbstractFullPdf
Dec 20217918161
Jan 20222087109
Feb 2022168234
Mar 202269323
Apr 202271016
May 2022133011
Jun 202249418
Jul 20223605
Aug 20223622
Sep 202246110
Oct 20224216
Nov 20222807
Dec 20222458
Jan 20233009
Feb 20232438
Mar 20232111
Apr 202340111
May 202324111
Jun 20231241
Jul 20231012
Aug 202321107
Sep 20231841
Oct 2023622
Nov 20233481
Dec 20232317
Jan 2024311
Feb 20242023
Mar 20241721
Apr 2024941
May 20241801
Jun 2024905
Jul 2024813
Aug 20241842
Sep 20241819
Oct 2024652
Nov 20241405
Dec 20242519
Jan 20251545
Feb 202515174
Mar 2025322918
Apr 202524118
May 202520411
Jun 2025241912
Jul 2025635626
Aug 2025031
Back to top
Posted December 21, 2021.
Download PDF

Supplementary Material

Data/Code
Email
SARS-CoV-2 vaccine effectiveness and breakthrough infections in maintenance dialysis patients
Harold J. Manley, Gideon N. Aweh, Caroline M. Hsu, Daniel E. Weiner, Dana Miskulin, Antonia M. Harford, Doug Johnson, Eduardo K. Lacson
medRxiv 2021.12.20.21268124; doi: https://doi.org/10.1101/2021.12.20.21268124
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area